Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo

BACKGROUND AND PURPOSE: The clinical use of arsenic trioxide (As(2)O(3)), a potent antineoplastic agent, is limited by its severe cardiotoxic effects. QT interval prolongation and apoptosis have been implicated in the cardiotoxicity of As(2)O(3). The present study was designed to evaluate the effect...

詳細記述

保存先:
書誌詳細
主要な著者: Zhao, X-Y, Li, G-Y, Liu, Y, Chai, L-M, Chen, J-X, Zhang, Y, Du, Z-M, Lu, Y-J, Yang, B-F
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2008
主題:
Research Papers
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2438979/
https://ncbi.nlm.nih.gov/pubmed/18332854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjp.2008.81
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料